SanBio Company Limited (4592.T)
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
928.00+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-60.7%
The outlook
SanBio Company Limited currently reads as leaning bearish based on hold — 2.6 avg of 5 analysts, below its 50- & 200-day averages, 2% of the way from its 52-week low to high, avg target +70% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusHold — 2.6 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +70% vs current price
Analyst price target
~12-month · 5 analysts1,580.00average target+70.3% vs now
Now 928.00
Low 1,200.00High 2,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$72.42B
52-wk high
3,990.00
52-wk low
874.00
50-day avg
1,122.64
200-day avg
1,825.72
Trailing P/E
—